Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide

  1. Erik Lee Snapp
  2. Nicholas McCaul
  3. Matthias Quandte
  4. Zuzana Cabartova
  5. Ilja Bontjer
  6. Carolina Källgren
  7. IngMarie Nilsson
  8. Aafke Land
  9. Gunnar von Heijne
  10. Rogier W Sanders
  11. Ineke Braakman  Is a corresponding author
  1. Janelia Research Campus, United States
  2. Utrecht University, Netherlands
  3. dr heinekamp Benelux B.V., Netherlands
  4. National Institute of Public Health, Czech Republic
  5. Academic Medical Center, Netherlands
  6. Stockholm University, Sweden
  7. Stockholm Unversity, Sweden
  8. Institute of Life Sciences, Netherlands

Abstract

Like all other secretory proteins, the HIV-1 envelope glycoprotein gp160, is targeted to the endoplasmic reticulum (ER) by its signal peptide during synthesis. Proper gp160 folding in the ER requires core glycosylation, disulfide-bond formation and proline isomerization. Signal-peptide cleavage occurs only late after gp160 chain termination and is dependent on folding of the soluble subunit gp120 to a near-native conformation. We here detail the mechanism by which co-translational signal-peptide cleavage is prevented. Conserved residues from the signal peptide and residues downstream of the canonical cleavage site form an extended alpha-helix in the ER membrane that covers the cleavage site, thus preventing cleavage. A point mutation in the signal peptide breaks the alpha helix allowing co-translational cleavage. We demonstrate that postponed cleavage of gp160 enhances functional folding of the molecule. The change to early cleavage results in decreased viral fitness compared to wild-type HIV.

Article and author information

Author details

  1. Erik Lee Snapp

    Janelia Research Campus, Ashburn, United States
    Competing interests
    Erik Lee Snapp, Has filed a patent application with and licensed technology to Lucigen Corp (U.S. Patent Application 15/152/908). The technology is not related to this manuscript..
  2. Nicholas McCaul

    Cellular Protein Chemistry, Utrecht University, Utrecht, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7888-7815
  3. Matthias Quandte

    dr heinekamp Benelux B.V., Riethoven, Netherlands
    Competing interests
    No competing interests declared.
  4. Zuzana Cabartova

    National Reference Laboratory for Viral Hepatitis, National Institute of Public Health, Šrobárova, Czech Republic
    Competing interests
    No competing interests declared.
  5. Ilja Bontjer

    Department of Medical Microbiology, Academic Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  6. Carolina Källgren

    Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  7. IngMarie Nilsson

    Department of Biochemistry and Biophysics, Stockholm Unversity, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  8. Aafke Land

    Hogeschool Utrecht, Institute of Life Sciences, Utrecht, Netherlands
    Competing interests
    No competing interests declared.
  9. Gunnar von Heijne

    Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4490-8569
  10. Rogier W Sanders

    Department of Medical Microbiology, Academic Medical Center, Amsterdam, Netherlands
    Competing interests
    Rogier W Sanders, Is listed as an inventor on patents involving recombinant, soluble native-like Env trimers (EP2975053A1, EP2765138A3, WO/2017/055522A1, WO/2011/108937, WO/2010/041942, WO/2008/103428A2, WO/2003/022869A2). The technology is not related to this manuscript..
  11. Ineke Braakman

    Cellular Protein Chemistry, Utrecht University, Utrecht, Netherlands
    For correspondence
    i.braakman@uu.nl
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1592-4364

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

  • Nicholas McCaul
  • Matthias Quandte
  • Aafke Land
  • Ineke Braakman

Netherlands AIDS Fund

  • Aafke Land

Seventh Framework Programme (ITN 'Virus Entry')

  • Nicholas McCaul
  • Matthias Quandte
  • Ineke Braakman

National Institutes of Health (NIH AI-51519)

  • Erik Lee Snapp

Swedish Cancer Foundation

  • IngMarie Nilsson
  • Gunnar von Heijne

Knut and Alice Wallenberg Foundation

  • Gunnar von Heijne

European Research Council (ERC-StG-2011-280829-SHEV)

  • Rogier W Sanders

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Reid Gilmore, University of Massachusetts Medical School, United States

Version history

  1. Received: February 27, 2017
  2. Accepted: July 26, 2017
  3. Accepted Manuscript published: July 28, 2017 (version 1)
  4. Version of Record published: August 23, 2017 (version 2)

Copyright

© 2017, Snapp et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,998
    views
  • 559
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Erik Lee Snapp
  2. Nicholas McCaul
  3. Matthias Quandte
  4. Zuzana Cabartova
  5. Ilja Bontjer
  6. Carolina Källgren
  7. IngMarie Nilsson
  8. Aafke Land
  9. Gunnar von Heijne
  10. Rogier W Sanders
  11. Ineke Braakman
(2017)
Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide
eLife 6:e26067.
https://doi.org/10.7554/eLife.26067

Share this article

https://doi.org/10.7554/eLife.26067

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Isabelle Petit-Hartlein, Annelise Vermot ... Franck Fieschi
    Research Article

    NADPH oxidases (NOX) are transmembrane proteins, widely spread in eukaryotes and prokaryotes, that produce reactive oxygen species (ROS). Eukaryotes use the ROS products for innate immune defense and signaling in critical (patho)physiological processes. Despite the recent structures of human NOX isoforms, the activation of electron transfer remains incompletely understood. SpNOX, a homolog from Streptococcus pneumoniae, can serves as a robust model for exploring electron transfers in the NOX family thanks to its constitutive activity. Crystal structures of SpNOX full-length and dehydrogenase (DH) domain constructs are revealed here. The isolated DH domain acts as a flavin reductase, and both constructs use either NADPH or NADH as substrate. Our findings suggest that hydride transfer from NAD(P)H to FAD is the rate-limiting step in electron transfer. We identify significance of F397 in nicotinamide access to flavin isoalloxazine and confirm flavin binding contributions from both DH and Transmembrane (TM) domains. Comparison with related enzymes suggests that distal access to heme may influence the final electron acceptor, while the relative position of DH and TM does not necessarily correlate with activity, contrary to previous suggestions. It rather suggests requirement of an internal rearrangement, within the DH domain, to switch from a resting to an active state. Thus, SpNOX appears to be a good model of active NOX2, which allows us to propose an explanation for NOX2’s requirement for activation.

    1. Biochemistry and Chemical Biology
    2. Plant Biology
    Dietmar Funck, Malte Sinn ... Jörg S Hartig
    Research Article

    Metabolism and biological functions of the nitrogen-rich compound guanidine have long been neglected. The discovery of four classes of guanidine-sensing riboswitches and two pathways for guanidine degradation in bacteria hint at widespread sources of unconjugated guanidine in nature. So far, only three enzymes from a narrow range of bacteria and fungi have been shown to produce guanidine, with the ethylene-forming enzyme (EFE) as the most prominent example. Here, we show that a related class of Fe2+- and 2-oxoglutarate-dependent dioxygenases (2-ODD-C23) highly conserved among plants and algae catalyze the hydroxylation of homoarginine at the C6-position. Spontaneous decay of 6-hydroxyhomoarginine yields guanidine and 2-aminoadipate-6-semialdehyde. The latter can be reduced to pipecolate by pyrroline-5-carboxylate reductase but more likely is oxidized to aminoadipate by aldehyde dehydrogenase ALDH7B in vivo. Arabidopsis has three 2-ODD-C23 isoforms, among which Din11 is unusual because it also accepted arginine as substrate, which was not the case for the other 2-ODD-C23 isoforms from Arabidopsis or other plants. In contrast to EFE, none of the three Arabidopsis enzymes produced ethylene. Guanidine contents were typically between 10 and 20 nmol*(g fresh weight)-1 in Arabidopsis but increased to 100 or 300 nmol*(g fresh weight)-1 after homoarginine feeding or treatment with Din11-inducing methyljasmonate, respectively. In 2-ODD-C23 triple mutants, the guanidine content was strongly reduced, whereas it increased in overexpression plants. We discuss the implications of the finding of widespread guanidine-producing enzymes in photosynthetic eukaryotes as a so far underestimated branch of the bio-geochemical nitrogen cycle and propose possible functions of natural guanidine production.